- BioProcess International
BioProcess International magazine covers the whole bioprocessing industry: biotherapeutic process and product development and biomanufacturing
- FDA cites contamination concerns in warning to Sanofi MA plant
Approximately 20% of bioreactor runs over 30 months were rejected due to contamination issues at Sanofi’s Framingham biologics facility, according to the US FDA
- BioProcess International March 2025 Issue 2025 - March | BioProcess . . .
BioProcess International March 2025 Downstream Processing issue Biopharmaceutical manufacturers today face a conundrum with big data Valuable information is abundant across product and process development, so the challenge lies not in accessing data, but in maximizing their potential value Mismanaged data can impede outcomes, and organizations that procure technology without clear purpose
- BioProcess International April 2025: Product Development Issue 2025 . . .
BioProcess International April 2025: Product Development Small, emerging biopharmaceutical companies account for over 65% of the clinical pipeline, driving industry innovation and early stage drug-development endeavors ( 1 ) Many such companies are uniquely positioned within the life-sciences industry, operating with lean teams that focus on speed and agility in drug development with limited
- About BioProcess International
BioProcess International™ provides the global industrial biotherapeutic community with peer-reviewed articles on the business, technologies, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through development and manufacturing
- Thermo Fisher expands India footprint with bioprocess design center
Biotechnology giant Thermo Fisher Scientific is constructing a bioprocess design facility in Hyderabad, Telangana, India
- Amgen ploughing $900m into Ohio production site
Amgen invests $900m in Ohio operations, expanding its US manufacturing footprint to 750 jobs, following recent $365m facility launch and $1 5bn North Carolina expansion
- BioProcess International US West 2025
SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing
|